Taurine chloramine inhibits production of nitric oxide and TNF-alpha in activated RAW 264.7 cells by mechanisms that involve transcriptional and translational events.
We previously reported that taurine chloramine (Tau-Cl) inhibits the production of both nitric oxide and TNF-alpha by activated RAW 264.7 cells. The current studies were conducted to gain insight into the mechanisms through which Tau-Cl exerts these effects. RAW 264.7 cells were activated by LPS (10 micrograms/ml) and rIFN-gamma (50 U/ml) in the absence or presence of either 0.8 mM Tau-Cl or taurine. Production of NO and TNF-alpha by RAW 264.7 cells was monitored: NO was measured spectrophotometrically as nitrite and TNF-alpha was measured by ELISA. Cell lysates were analyzed for the inducible form of nitric oxide synthase (iNOS) by Western blot analyses, and TNF-alpha and iNOS mRNAs were assessed by northern blot analyses. Tau-Cl inhibited transcription of the iNOS gene, or some earlier event in the signal transduction pathway, because iNOS protein and iNOS mRNA were undetected in lysates of cells activated in the continuous presence of Tau-Cl. In contrast, steady-state levels of TNF-alpha mRNA increased in the presence of Tau-Cl to at least the same extent as that in untreated activated cells and persisted for a longer period of time. Metabolic labeling experiments demonstrated that Tau-Cl inhibited translation of TNF-alpha mRNA because the presence of the presecretory 26-kDa form and the secreted 17-kDa form of TNF-alpha were greatly reduced in lysates and culture media, respectively, of cells activated in the presence of Tau-Cl. Inhibition of TNF-alpha synthesis by Tau-Cl is not the result of a generalized effect on protein synthesis because the amount of radiolabeled protein precipitated from metabolically labeled cells by TCA was unaffected by Tau-Cl, and cell viability was unaffected. The results of these studies demonstrate that Tau-Cl decreases production of tissue-damaging inflammatory mediators and thus may act as a physiologic modulator of macrophage function.
Park
E
E
Department of Immunology, New York State Institute for Basic Research in Developmental Disabilities, Staten Island 10314, USA.
Schuller-Levis
G
G
Quinn
M R
MR
D000594:Amino Acid Oxidoreductases / Q000096:biosynthesis; D000818:Animals; D015152:Blotting, Northern; D015153:Blotting, Western; D002460:Cell Line; D051379:Mice; D009569:Nitric Oxide / Q000096:biosynthesis*; D019001:Nitric Oxide Synthase; D014176:Protein Biosynthesis / Q000187:drug effects*; D013654:Taurine / Q000031:analogs & derivatives* / Q000494:pharmacology; D014158:Transcription, Genetic / Q000187:drug effects*; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis*
D014409:Tumor Necrosis Factor-alpha; D013654:Taurine; D009569:Nitric Oxide; C043410:N-chlorotaurine; D019001:Nitric Oxide Synthase; D000594:Amino Acid Oxidoreductases